← 返回靶基因列表
🔬 剪接因子 FUBP1 靶基因疾病富集分析
| 疾病名称 | Overlap | P-value | 富集倍数 | 相关靶基因 |
|---|---|---|---|---|
| hemorrhoid | 4/4 | 0.008041 | 3.32x | SFMBT1, CCNL1, CCAR2, SND1 |
| Duodenal Adenocarcinoma | 20/43 | 0.014035 | 1.54x | FUS, SF3B1, THRAP3, SFPQ, EWSR1, HNRNPA2B1, QKI, ZCCHC8, NUMA1, U2AF1, PSIP1, NONO, FUBP1, CPEB3, DDX5, SPEN, RBM10, DDX6, DDX3X, SND1 |
| breast ductal adenocarcinoma | 26/60 | 0.015757 | 1.44x | FUS, SF3B1, THRAP3, SFPQ, PCBP1, PABPC1, EWSR1, HNRNPA2B1, RBM15, QKI, ZCCHC8, NUMA1, U2AF1, AKAP1, PSIP1, NONO, FUBP1, CPEB3, SRSF2, DDX5 |
| clear cell renal carcinoma | 26/60 | 0.015757 | 1.44x | FUS, SF3B1, THRAP3, SFPQ, PCBP1, PABPC1, EWSR1, HNRNPA2B1, RBM15, QKI, ZCCHC8, NUMA1, U2AF1, SFMBT1, PSIP1, NONO, FUBP1, CPEB3, SRSF2, DDX5 |
| Gallbladder Adenocarcinoma | 18/38 | 0.015806 | 1.57x | NUMA1, FUS, SF3B1, FUBP1, DDX5, SPEN, SFPQ, U2AF1, RBM10, THRAP3, HNRNPA2B1, PSIP1, NONO, DDX6, DDX3X, SND1, PABPC1, CPEB3 |
| multiple myeloma | 22/49 | 0.016403 | 1.49x | FUS, SF3B1, THRAP3, PABPC1, EWSR1, HNRNPA2B1, RBM15, QKI, NUMA1, U2AF1, PSIP1, NONO, FUBP1, EFTUD2, CPEB3, SRSF2, DDX5, SPEN, RBM10, DDX6 |
| lung adenocarcinoma | 27/63 | 0.016450 | 1.42x | FUS, SF3B1, THRAP3, SFPQ, PCBP1, PABPC1, EWSR1, HNRNPA2B1, RBM15, YBX1, QKI, IGF2BP3, ZCCHC8, NUMA1, U2AF1, PSIP1, NONO, FUBP1, CPEB3, SRSF2 |
| thyroid carcinoma | 24/55 | 0.018425 | 1.45x | FUS, SF3B1, THRAP3, SFPQ, PABPC1, EWSR1, HNRNPA2B1, RBM15, QKI, ZCCHC8, NUMA1, U2AF1, PSIP1, NONO, FUBP1, CPEB3, SRSF2, DDX5, SPEN, RBM10 |
| skin basal cell carcinoma | 24/55 | 0.018425 | 1.45x | FUS, SF3B1, THRAP3, SFPQ, PABPC1, EWSR1, HNRNPA2B1, RBM15, QKI, ZCCHC8, NUMA1, U2AF1, PSIP1, NONO, FUBP1, CPEB3, SRSF2, DDX5, SPEN, RBM10 |
| carcinoma of liver and intrahepatic biliary tract | 24/55 | 0.018425 | 1.45x | FUS, SF3B1, THRAP3, SFPQ, PABPC1, EWSR1, HNRNPA2B1, RBM15, QKI, ZCCHC8, NUMA1, U2AF1, PSIP1, NONO, FUBP1, CPEB3, SRSF2, DDX5, SPEN, RBM10 |
| bile duct carcinoma | 24/55 | 0.018425 | 1.45x | FUS, SF3B1, THRAP3, SFPQ, PABPC1, EWSR1, HNRNPA2B1, RBM15, QKI, ZCCHC8, NUMA1, U2AF1, PSIP1, NONO, FUBP1, CPEB3, SRSF2, DDX5, SPEN, RBM10 |
| cecum adenocarcinoma | 24/55 | 0.018425 | 1.45x | FUS, SF3B1, THRAP3, SFPQ, PCBP1, PABPC1, EWSR1, HNRNPA2B1, RBM15, QKI, ZCCHC8, NUMA1, U2AF1, PSIP1, NONO, FUBP1, CPEB3, DDX5, SPEN, RBM10 |
| rectal adenocarcinoma | 25/58 | 0.019309 | 1.43x | FUS, SF3B1, THRAP3, SFPQ, PCBP1, PABPC1, EWSR1, HNRNPA2B1, RBM15, QKI, ZCCHC8, NUMA1, U2AF1, PSIP1, NONO, FUBP1, CPEB3, SRSF2, DDX5, SPEN |
| Extramammary Paget Disease | 10/18 | 0.019991 | 1.85x | NUMA1, FUS, DDX5, SPEN, SFPQ, RBM10, PSIP1, DDX3X, SND1, QKI |
| pulmonary large cell neuroendocrine carcinoma | 12/23 | 0.020106 | 1.73x | ZCCHC8, SF3B1, DDX5, THRAP3, SFPQ, RBM10, HNRNPA2B1, PSIP1, FUBP1, DDX3X, SND1, QKI |
| squamous cell lung carcinoma | 26/61 | 0.020111 | 1.42x | FUS, SF3B1, THRAP3, SFPQ, PCBP1, PABPC1, EWSR1, HNRNPA2B1, RBM15, QKI, ZCCHC8, NUMA1, U2AF1, PSIP1, NONO, FUBP1, CPEB3, SRSF2, DDX5, SPEN |
| head and neck squamous cell carcinoma | 26/61 | 0.020111 | 1.42x | FUS, SF3B1, THRAP3, KHDRBS1, SFPQ, PCBP1, PABPC1, EWSR1, HNRNPA2B1, RBM15, QKI, ZCCHC8, NUMA1, U2AF1, PSIP1, NONO, FUBP1, CPEB3, SRSF2, DDX5 |
| soft tissue sarcoma | 21/47 | 0.020225 | 1.48x | FUS, SF3B1, SFPQ, EWSR1, HNRNPA2B1, RBM15, QKI, ZCCHC8, NUMA1, U2AF1, PSIP1, NONO, CPEB3, SRSF2, DDX5, SPEN, RBM10, SRSF3, DDX6, DDX3X |
| neoplasm | 45/117 | 0.020619 | 1.28x | SF3B1, NUDT21, SRSF1, DKC1, THRAP3, KHDRBS1, SFPQ, HNRNPK, CPEB4, PCBP1, FMR1, MBNL1, ELAVL1, EWSR1, PPIH, HNRNPA2B1, RBM15, YBX1, QKI, IGF2BP3 |
| central nervous system primitive neuroectodermal neoplasm | 22/50 | 0.021467 | 1.46x | FUS, SF3B1, THRAP3, SFPQ, PABPC1, EWSR1, HNRNPA2B1, RBM15, QKI, NUMA1, U2AF1, PSIP1, NONO, FUBP1, CPEB3, SRSF2, DDX5, SPEN, RBM10, DDX6 |
| brain glioblastoma | 23/53 | 0.022598 | 1.44x | FUS, SF3B1, THRAP3, SFPQ, PABPC1, EWSR1, HNRNPA2B1, RBM15, QKI, ZCCHC8, NUMA1, U2AF1, PSIP1, NONO, FUBP1, SRSF2, DDX5, SPEN, RBM10, SRSF3 |
| gastric carcinoma | 24/56 | 0.023621 | 1.42x | FUS, SF3B1, THRAP3, SFPQ, PABPC1, EWSR1, HNRNPA2B1, RBM15, QKI, ZCCHC8, NUMA1, U2AF1, PSIP1, NONO, FUBP1, CPEB3, SRSF2, DDX5, SPEN, RBM10 |
| bladder transitional cell carcinoma | 25/59 | 0.024542 | 1.41x | FUS, SF3B1, THRAP3, SFPQ, PCBP1, PABPC1, EWSR1, HNRNPA2B1, RBM15, QKI, ZCCHC8, NUMA1, U2AF1, PSIP1, NONO, FUBP1, CPEB3, SRSF2, DDX5, SPEN |
| colon adenocarcinoma | 25/59 | 0.024542 | 1.41x | FUS, SF3B1, THRAP3, SFPQ, PCBP1, PABPC1, EWSR1, HNRNPA2B1, RBM15, QKI, ZCCHC8, NUMA1, U2AF1, PSIP1, NONO, FUBP1, CPEB3, SRSF2, DDX5, SPEN |
| colorectal adenocarcinoma | 25/59 | 0.024542 | 1.41x | FUS, SF3B1, THRAP3, SFPQ, PCBP1, PABPC1, EWSR1, HNRNPA2B1, RBM15, QKI, ZCCHC8, NUMA1, U2AF1, PSIP1, NONO, FUBP1, CPEB3, SRSF2, DDX5, SPEN |
| gastric adenocarcinoma | 25/59 | 0.024542 | 1.41x | FUS, SF3B1, THRAP3, SFPQ, PCBP1, PABPC1, EWSR1, HNRNPA2B1, RBM15, QKI, ZCCHC8, NUMA1, U2AF1, PSIP1, NONO, FUBP1, CPEB3, SRSF2, DDX5, SPEN |
| pancreatic ductal adenocarcinoma | 25/59 | 0.024542 | 1.41x | FUS, SF3B1, THRAP3, SFPQ, PCBP1, PABPC1, EWSR1, HNRNPA2B1, RBM15, QKI, ZCCHC8, NUMA1, U2AF1, PSIP1, NONO, FUBP1, CPEB3, SRSF2, DDX5, SPEN |
| Endometrial Endometrioid Adenocarcinoma | 25/59 | 0.024542 | 1.41x | FUS, SF3B1, THRAP3, SFPQ, PCBP1, PABPC1, EWSR1, HNRNPA2B1, RBM15, QKI, ZCCHC8, NUMA1, U2AF1, PSIP1, NONO, FUBP1, CPEB3, SRSF2, DDX5, SPEN |
| bile duct adenocarcinoma | 20/45 | 0.024911 | 1.48x | FUS, SF3B1, SFPQ, PABPC1, EWSR1, HNRNPA2B1, RBM15, QKI, NUMA1, U2AF1, PSIP1, NONO, FUBP1, DDX5, SPEN, RBM10, SRSF3, DDX6, DDX3X, SND1 |
| urinary bladder carcinoma | 27/65 | 0.026098 | 1.38x | FUS, SF3B1, THRAP3, SFPQ, PCBP1, PABPC1, EWSR1, CWC27, HNRNPA2B1, RBM15, QKI, IGF2BP3, ZCCHC8, NUMA1, U2AF1, PSIP1, NONO, FUBP1, CPEB3, SRSF2 |
💡 说明：
• Overlap: 靶基因中与该疾病相关的基因数 / 数据库中该疾病总关联基因数
• P-value: 超几何检验显著性，越小代表富集越显著
• 富集倍数: 实际关联数 / 期望关联数，>1 表示富集
• Overlap: 靶基因中与该疾病相关的基因数 / 数据库中该疾病总关联基因数
• P-value: 超几何检验显著性，越小代表富集越显著
• 富集倍数: 实际关联数 / 期望关联数，>1 表示富集